Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1991-01-22
1992-06-23
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
514922, A61K 3704
Patent
active
051241463
ABSTRACT:
A method for the delivery of therapeutic agents across the blood brain barrier is disclosed which utilizes drug neutralization technology, and the selective permeability o
REFERENCES:
patent: 4351831 (1982-09-01), Growdon et al.
patent: 4363793 (1982-12-01), Blau et al.
patent: 4479932 (1984-10-01), Bodor
patent: 4540564 (1985-09-01), Bodor
patent: 4622218 (1986-11-01), Bodor
patent: 4624846 (1986-11-01), Goldenberg
patent: 4634586 (1987-01-01), Goodwin et al.
Neuwelt et al., "Characterization of a New Model of G.sub.M2 -Gangliosidosis (Sandhoff's Disease) in Korat Cats," J. Clin. Invest. 76:482-490 (1985).
Neuwelt et al., "Osmotic Blood-Brain Barrier Opening to IgM Monoclonal Antibody in the Rat," Am. J. Physiol. 250:R873-R883 (1986).
Neuwelt et al., "Cerebrovascular Permeability and Delivery of Gentamicin to Normal Brain and Experimental Brain Abscess in Rats," J. Neurosurg. 61:430-439 (1984).
Neuwelt et al., "Osmotic Blood-Brain Barrier Modification: Monoclonal Antibody, Albumin, and Methotrexate Delivery to Cerebrospinal Fluid and Brain," Neurosurg. 17:419-423 (1985).
Sage, "Blood-Brain Barrier: Phenomenon of Increasing Importance to the Imaging Clinician," J. Am. J. Roentgenol. 138:887-898 (1982).
Neuwelt et al., "Growth of Human Lung Tumor in the Brain of the Nude Rat as a Model to Evaluate Antitumor Agent Delivery Across the Blood-Brain Barrier," Cancer Research 45:2827-2833 (1985).
Greig, "Chemotheraphy of Brain Metastases: Current Status," Cancer Treatment Reviews 11:157-186 (1984).
Sharkey et al., "Factors Influencing Anti-Antibody Enhancement of Tumor Targeting with Antibodies in Hamsters with Human Colonic Tumor Xenografts," Cancer Research 48:2005-2009 (1988).
Hiesiger et al., "Opening the Blood-Brain and Blood-Tumor Barriers in Experimental Rat Brain Tumors: The Effect of Intracarotid Hyperosmolar Mannitol on Capillary Permeability and Blood Flow," Annals of Neurology 19:50-59 (1986).
Neuwelt et al., "Permeability of Human Brain Tumor to 99mTC-glucoheptonate and 99mTc-albumin," J. Neurosurg. 65:194-198 (1986).
Neuwelt et al., "Increased Delivery of Tumor-Specific Monoclonal Antibodies to Brain After Osmotic Blood-Brain Barrier Modification in Patients with Malanoma Metastatic to the Central Nervous System," Neurosurgery 20:885-895 (1987).
Barranger et al., "Modification of the Blood-Brain Barrier: Increased Concentration and Fate of Enzymes Entering the Brain," Proc. Natl. Acad. Sci. U.S.A. 76:481-485 (1979).
Blasberg et al., "Regional Localization of a Glioma-Associated Antigen Defined by Monoclonal Antibody 81C6 in Vivo: Kinetics and Implications for Diagnosis and Therapy," Cancer Research 47:4432-4443 (1987).
Smith et al., "Treatment of Life-Threatening Digitalis Intoxication with Digoxin-Specific Fab Antibody Fragments," New Engl. J. of Med. 307:1357-1362 (1982).
Blasberg et al., "Concurrent Measurements of Blood Flow and Transcapillary Transport in ASV-Induced Experimental Brain Tumors: Implications for Brain Tumor Chemotherapy," J. Pharmacol. Exp. Ther. 231:724-735 (1984).
Groothuis et al., "Regional Blood Flow and Blood-to-Tissue Transport in Five Brain Tumor Models," in Rosenblum et al. (eds.), Prog. Exp. Tumor Res. 27:132-153 (1984).
Cashion Jr. Merrell C.
Koh Choon
The State of Oregon Acting by and through the State Board of Hig
LandOfFree
Differential delivery of therapeutic agents across the blood bra does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Differential delivery of therapeutic agents across the blood bra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Differential delivery of therapeutic agents across the blood bra will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-931743